STAAR Surgical Stock Price, News & Analysis (NASDAQ:STAA)

$16.00 0.00 (0.00 %)
(As of 12/13/2017 03:58 AM ET)
Previous Close$16.00
Today's Range$15.95 - $16.65
52-Week Range$8.95 - $17.60
Volume133,400 shs
Average Volume94,122 shs
Market Capitalization$664.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19

About STAAR Surgical (NASDAQ:STAA)

STAAR Surgical logoSTAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902

Debt

Debt-to-Equity Ratio0.02%
Current Ratio2.24%
Quick Ratio1.72%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$82.43 million
Price / Sales7.99
Cash FlowN/A
Price / CashN/A
Book Value$0.93 per share
Price / Book17.20

Profitability

Trailing EPS($0.04)
Net Income$-12,120,000.00
Net Margins-2.47%
Return on Equity-3.34%
Return on Assets-1.93%

Miscellaneous

Employees336
Outstanding Shares41,160,000

STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical's earnings last quarter?

STAAR Surgical Company (NASDAQ:STAA) issued its quarterly earnings results on Thursday, November, 3rd. The medical instruments supplier reported ($0.02) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.04) by $0.02. The medical instruments supplier earned $20.05 million during the quarter, compared to the consensus estimate of $20.70 million. STAAR Surgical had a negative return on equity of 3.34% and a negative net margin of 2.47%. The firm's revenue for the quarter was up 6.9% compared to the same quarter last year. View STAAR Surgical's Earnings History.

When will STAAR Surgical make its next earnings announcement?

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Thursday, March, 1st 2018. View Earnings Estimates for STAAR Surgical.

Where is STAAR Surgical's stock going? Where will STAAR Surgical's stock price be in 2017?

2 analysts have issued 12-month price targets for STAAR Surgical's stock. Their forecasts range from $20.00 to $21.00. On average, they expect STAAR Surgical's stock price to reach $20.50 in the next year. View Analyst Ratings for STAAR Surgical.

Who are some of STAAR Surgical's key competitors?

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the folowing people:

  • Caren L. Mason, President, Chief Executive Officer, Director (Age 63)
  • Deborah J. Andrews, Chief Financial Officer, Vice President (Age 59)
  • Hans-Martin Blickensdoerfer, Senior Vice President - Commercial Operations for Europe, Middle East, Africa, Latin America and China. (Age 52)
  • James E. Francese, Senior Vice President of North American and APAC (Age 51)
  • Keith Holliday Ph.D., Chief Technology Officer, Vice President (Age 54)
  • Surindra Mann, Vice President - Global Financial Planning and Analysis
  • William Walter Goodmen, Vice President - Global Human Resources (Age 60)
  • Jon K. Hayashida, Vice President - Global Clinical and Medical Affairs
  • Philippe Subrin, Vice President-ICL Manufacturing (Age 51)
  • Samuel J. Gesten, Vice President - Business Development, Chief Legal Officer and Secretary (Age 55)

Who owns STAAR Surgical stock?

STAAR Surgical's stock is owned by many different of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (1.70%), Cortina Asset Management LLC (1.21%), Rice Hall James & Associates LLC (0.40%), California State Teachers Retirement System (0.16%), Wells Fargo & Company MN (0.16%) and Quantum Capital Management (0.14%). Company insiders that own STAAR Surgical stock include Broadwood Partners Lp, Hans-Martin Blickensdoerfer, Keith Holliday and Richard A Meier. View Institutional Ownership Trends for STAAR Surgical.

Who sold STAAR Surgical stock? Who is selling STAAR Surgical stock?

STAAR Surgical's stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC, Campbell & CO Investment Adviser LLC, Susquehanna International Group LLP and California State Teachers Retirement System. View Insider Buying and Selling for STAAR Surgical.

Who bought STAAR Surgical stock? Who is buying STAAR Surgical stock?

STAAR Surgical's stock was bought by a variety of institutional investors in the last quarter, including Rice Hall James & Associates LLC, Quantum Capital Management, Baillie Gifford & Co., Raymond James Financial Services Advisors Inc., Citadel Advisors LLC, Wells Fargo & Company MN, Prudential Financial Inc. and Trexquant Investment LP. View Insider Buying and Selling for STAAR Surgical.

How do I buy STAAR Surgical stock?

Shares of STAAR Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical's stock price today?

One share of STAAR Surgical stock can currently be purchased for approximately $16.00.

How big of a company is STAAR Surgical?

STAAR Surgical has a market capitalization of $664.80 million and generates $82.43 million in revenue each year. The medical instruments supplier earns $-12,120,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. STAAR Surgical employs 336 workers across the globe.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 1911 WALKER AVE, MONROVIA CA, 91016. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]


MarketBeat Community Rating for STAAR Surgical (STAA)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  189 (Vote Underperform)
Total Votes:  291
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STAAR Surgical (NASDAQ:STAA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.672.672.252.25
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $20.50$15.00$12.00$10.50
Price Target Upside: 25.77% upside20.48% upside0.42% upside3.19% upside

STAAR Surgical (NASDAQ:STAA) Consensus Price Target History

Price Target History for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2017BenchmarkReiterated RatingBuy -> Buy$21.00N/AView Rating Details
11/17/2017Canaccord GenuityBoost Price TargetBuy$17.50 -> $20.00N/AView Rating Details
8/4/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

STAAR Surgical (NASDAQ:STAA) Earnings History and Estimates Chart

Earnings by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018N/AView Earnings Details
8/2/2017Q2 2017($0.05)($0.01)$22.15 million$21.90 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.05)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

STAAR Surgical (NASDAQ:STAA) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $0.19 EPS

Dividends

Dividend History for STAAR Surgical (NASDAQ:STAA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

STAAR Surgical (NASDAQ STAA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.40%
Institutional Ownership Percentage: 77.73%
Insider Trades by Quarter for STAAR Surgical (NASDAQ:STAA)
Institutional Ownership by Quarter for STAAR Surgical (NASDAQ:STAA)

STAAR Surgical (NASDAQ STAA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2017Keith HollidayVPSell6,000$16.65$99,900.00View SEC Filing  
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.00View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.00View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.00View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.52View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.92View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.00View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.75View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.98View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.59View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STAAR Surgical (NASDAQ STAA) News Headlines

Source:
DateHeadline
STAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per ShareSTAAR Surgical Company (STAA) Expected to Announce Earnings of $0.03 Per Share
www.americanbankingnews.com - December 7 at 11:32 PM
Analysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per ShareAnalysts Expect STAAR Surgical Company (STAA) to Announce $0.03 Earnings Per Share
www.americanbankingnews.com - November 27 at 4:26 PM
STAAR Surgical Company (STAA) VP Sells $99,900.00 in StockSTAAR Surgical Company (STAA) VP Sells $99,900.00 in Stock
www.americanbankingnews.com - November 22 at 2:03 PM
Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)Benchmark Co. Reiterates "Buy" Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - November 20 at 9:50 AM
Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00Canaccord Genuity Boosts STAAR Surgical Company (STAA) Price Target to $20.00
www.americanbankingnews.com - November 17 at 5:28 PM
STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017STAAR Surgical Announces Webcast of Upcoming Investor and Analyst Day on November 16, 2017
finance.yahoo.com - November 15 at 12:10 PM
Comparing STAAR Surgical (STAA) and Sientra (SIEN)Comparing STAAR Surgical (STAA) and Sientra (SIEN)
www.americanbankingnews.com - November 15 at 1:24 AM
STAARs (STAA) CEO Caren Mason on Q3 2017 Results - Earnings Call TranscriptSTAAR's (STAA) CEO Caren Mason on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 11:11 AM
EARNINGS SUMMARY: Details of STAAR Surgical Company Q3 Earnings ReportEARNINGS SUMMARY: Details of STAAR Surgical Company Q3 Earnings Report
www.rttnews.com - November 10 at 11:11 AM
Zacks: STAAR Surgical Company (STAA) Given Consensus Rating of "Buy" by BrokeragesZacks: STAAR Surgical Company (STAA) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 9 at 3:52 PM
STAAR Surgical Company to Host Earnings CallSTAAR Surgical Company to Host Earnings Call
finance.yahoo.com - November 9 at 2:02 PM
STAAR Surgical Reports Third Quarter 2017 ResultsSTAAR Surgical Reports Third Quarter 2017 Results
finance.yahoo.com - November 9 at 2:02 PM
Staar Surgical posts 3Q profitStaar Surgical posts 3Q profit
finance.yahoo.com - November 9 at 2:02 PM
Edited Transcript of STAA earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of STAA earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 2:02 PM
STAAR Surgical Company (STAA) Announces Quarterly  Earnings ResultsSTAAR Surgical Company (STAA) Announces Quarterly Earnings Results
www.americanbankingnews.com - November 8 at 7:56 PM
$0.02 EPS Expected for STAAR Surgical Company (STAA) This Quarter$0.02 EPS Expected for STAAR Surgical Company (STAA) This Quarter
www.americanbankingnews.com - October 30 at 3:24 PM
STAAR Surgical to Report Third Quarter Results on November 8, 2017STAAR Surgical to Report Third Quarter Results on November 8, 2017
finance.yahoo.com - October 25 at 11:14 AM
STAAR Surgical Company (STAA) Set to Announce Earnings on WednesdaySTAAR Surgical Company (STAA) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 25 at 5:44 AM
Ophthalmic Surgical Technologies Market to Grow due to Growing Adoption of Robotic Surgical InstrumentationOphthalmic Surgical Technologies Market to Grow due to Growing Adoption of Robotic Surgical Instrumentation
globenewswire.com - October 24 at 10:36 AM
STAAR Surgical Company (STAA) Given New $15.00 Price Target at Benchmark Co.STAAR Surgical Company (STAA) Given New $15.00 Price Target at Benchmark Co.
www.americanbankingnews.com - October 21 at 12:38 AM
Zacks Investment Research Lowers STAAR Surgical Company (STAA) to HoldZacks Investment Research Lowers STAAR Surgical Company (STAA) to Hold
www.americanbankingnews.com - October 11 at 8:28 PM
Short Interest Declines 16.4% For STAAShort Interest Declines 16.4% For STAA
www.thestreet.com - October 11 at 3:27 PM
$0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter$0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter
www.americanbankingnews.com - October 11 at 2:16 PM
Canaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA)Canaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA)
www.americanbankingnews.com - October 9 at 2:34 PM
STAAR Surgical (STAA) & The Competition Head-To-Head ReviewSTAAR Surgical (STAA) & The Competition Head-To-Head Review
www.americanbankingnews.com - October 7 at 12:18 AM
STAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical OfficerSTAAR Surgical Appoints Scott D. Barnes, M.D. as Chief Medical Officer
finance.yahoo.com - October 3 at 12:59 PM
STAAR Surgical (STAA) versus Haemonetics Corporation (HAE) Critical ComparisonSTAAR Surgical (STAA) versus Haemonetics Corporation (HAE) Critical Comparison
www.americanbankingnews.com - October 2 at 12:22 AM
STAAR Surgical Names Deborah Andrews as CFO - PR Newswire (press release)STAAR Surgical Names Deborah Andrews as CFO - PR Newswire (press release)
www.prnewswire.com - September 29 at 7:46 AM
DexCom (DXCM) vs. STAAR Surgical (STAA) Head-To-Head AnalysisDexCom (DXCM) vs. STAAR Surgical (STAA) Head-To-Head Analysis
www.americanbankingnews.com - September 28 at 2:28 PM
STAAR Surgical Names Deborah Andrews as CFOSTAAR Surgical Names Deborah Andrews as CFO
www.bizjournals.com - September 28 at 12:05 PM
STAAR Surgical Company (STAA) Upgraded to "Buy" by Canaccord GenuitySTAAR Surgical Company (STAA) Upgraded to "Buy" by Canaccord Genuity
www.americanbankingnews.com - September 26 at 12:28 AM
ETFs with exposure to STAAR Surgical Co. : September 22, 2017ETFs with exposure to STAAR Surgical Co. : September 22, 2017
finance.yahoo.com - September 23 at 8:48 AM
STAAR Surgical (STAA) & Bio-Rad Laboratories (BIO) Head-To-Head ContrastSTAAR Surgical (STAA) & Bio-Rad Laboratories (BIO) Head-To-Head Contrast
www.americanbankingnews.com - September 16 at 4:42 AM
STAAR Surgical (STAA) & The Competition Head to Head ReviewSTAAR Surgical (STAA) & The Competition Head to Head Review
www.americanbankingnews.com - September 12 at 12:28 AM
STAAR Surgical Company (STAA) Stock Rating Reaffirmed by Canaccord GenuitySTAAR Surgical Company (STAA) Stock Rating Reaffirmed by Canaccord Genuity
www.americanbankingnews.com - September 10 at 10:10 PM
InspireMD (NSPR) & STAAR Surgical (STAA) Head to Head ComparisonInspireMD (NSPR) & STAAR Surgical (STAA) Head to Head Comparison
www.americanbankingnews.com - September 7 at 4:28 AM
TheStreet Upgrades STAAR Surgical Company (STAA) to CTheStreet Upgrades STAAR Surgical Company (STAA) to C
www.americanbankingnews.com - August 17 at 12:26 PM
Corporate News Blog - STAAR Surgical Announces Strategic Cooperation Agreement with Seoul/Busan Eye ClinicCorporate News Blog - STAAR Surgical Announces Strategic Cooperation Agreement with Seoul/Busan Eye Clinic
finance.yahoo.com - August 17 at 7:58 AM
STAAR Surgical and Seoul/Busan BalGeunSeSang Eye Clinic Announce Strategic Cooperation AgreementSTAAR Surgical and Seoul/Busan BalGeunSeSang Eye Clinic Announce Strategic Cooperation Agreement
finance.yahoo.com - August 15 at 7:22 AM
STAAR Surgical Company (NASDAQ:STAA) Price Target Raised to $13.00 at Benchmark Co.STAAR Surgical Company (NASDAQ:STAA) Price Target Raised to $13.00 at Benchmark Co.
www.americanbankingnews.com - August 14 at 8:36 AM
 Brokerages Set $11.67 Target Price for STAAR Surgical Company (STAA) Brokerages Set $11.67 Target Price for STAAR Surgical Company (STAA)
www.americanbankingnews.com - August 11 at 11:14 PM
STAAR Surgical (STAA) versus OraSure Technologies (OSUR) Head-To-Head ComparisonSTAAR Surgical (STAA) versus OraSure Technologies (OSUR) Head-To-Head Comparison
www.americanbankingnews.com - August 6 at 2:22 PM
STAAR Surgical Company (NASDAQ:STAA) Releases Quarterly  Earnings Results, Beats Expectations By $0.04 EPSSTAAR Surgical Company (NASDAQ:STAA) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - August 3 at 9:21 PM
STAAR Surgical Company (NASDAQ:STAA) Price Target Increased to $11.00 by Analysts at Canaccord GenuitySTAAR Surgical Company (NASDAQ:STAA) Price Target Increased to $11.00 by Analysts at Canaccord Genuity
www.americanbankingnews.com - August 3 at 6:06 PM
STAARs (STAA) CEO Caren Mason on Q2 2017 Results - Earnings Call TranscriptSTAAR's (STAA) CEO Caren Mason on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 3 at 7:34 AM
EARNINGS SUMMARY: Details of STAAR Surgical Company Q2 Earnings ReportEARNINGS SUMMARY: Details of STAAR Surgical Company Q2 Earnings Report
www.rttnews.com - August 3 at 7:34 AM
STAAR Surgical Reports Second Quarter 2017 ResultsSTAAR Surgical Reports Second Quarter 2017 Results
finance.yahoo.com - August 3 at 7:34 AM
Edited Transcript of STAA earnings conference call or presentation 2-Aug-17 8:30pm GMTEdited Transcript of STAA earnings conference call or presentation 2-Aug-17 8:30pm GMT
finance.yahoo.com - August 3 at 7:34 AM
Staar Surgical reports 2Q lossStaar Surgical reports 2Q loss
finance.yahoo.com - August 3 at 7:34 AM
Critical Comparison: STAAR Surgical (STAA) versus OraSure Technologies (OSUR)Critical Comparison: STAAR Surgical (STAA) versus OraSure Technologies (OSUR)
www.americanbankingnews.com - July 31 at 9:32 AM

SEC Filings

STAAR Surgical (NASDAQ:STAA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STAAR Surgical (NASDAQ:STAA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STAAR Surgical (NASDAQ STAA) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.